Ubs Group Ag Sc Pharmaceuticals Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Ubs Group Ag holds 19,504 shares of SCPH stock, worth $66,703. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,504

Previous 8,770 122.39%

Holding current value

$66,703

Previous $38,000 131.58%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.12 - $5.51 $44,224 - $59,144	10,734 Added 122.39%	19,504 $88,000
Q2 2024 Aug 13, 2024	SELL	$3.51 - $5.21 $89,378 - $132,667	-25,464 Reduced 74.38%	8,770 $38,000
Q1 2024 May 13, 2024	BUY	$4.86 - $6.39 $23,031 - $30,282	4,739 Added 16.07%	34,234 $171,000
Q4 2023 Feb 09, 2024	BUY	$4.7 - $6.63 $70,326 - $99,204	14,963 Added 102.97%	29,495 $184,000
Q3 2023 Nov 09, 2023	SELL	$7.0 - $9.82 $15,155 - $21,260	-2,165 Reduced 12.97%	14,532 $103,000
Q2 2023 Aug 11, 2023	BUY	$8.94 - $11.74 $149,271 - $196,022	16,697 New	16,697 $170,000
Q4 2022 Feb 08, 2023	BUY	$4.02 - $7.53 $12,421 - $23,267	3,090 New	3,090 $22,000
Q2 2022 Aug 10, 2022	BUY	$4.3 - $6.48 $4,953 - $7,464	1,152 Added 115.2%	2,152 $10,000
Q1 2022 May 16, 2022	SELL	$3.9 - $6.11 $4,886 - $7,655	-1,253 Reduced 55.61%	1,000 $6,000
Q4 2021 Feb 14, 2022	BUY	$3.88 - $6.9 $5,470 - $9,729	1,410 Added 167.26%	2,253 $11,000
Q3 2021 Nov 15, 2021	BUY	$4.93 - $7.15 $685 - $993	139 Added 19.74%	843 $6,000
Q2 2021 Aug 13, 2021	SELL	$5.19 - $7.38 $8,719 - $12,398	-1,680 Reduced 70.47%	704 $4,000
Q1 2021 May 12, 2021	BUY	$5.65 - $7.66 $3,734 - $5,063	661 Added 38.36%	2,384 $16,000
Q4 2020 Feb 11, 2021	BUY	$5.17 - $9.41 $5,128 - $9,334	992 Added 135.7%	1,723 $9,000
Q3 2020 Nov 12, 2020	SELL	$7.12 - $8.86 $7,219 - $8,984	-1,014 Reduced 58.11%	731 $5,000
Q2 2020 Jul 31, 2020	BUY	$7.01 - $10.96 $9,835 - $15,376	1,403 Added 410.23%	1,745 $13,000
Q1 2020 May 01, 2020	SELL	$5.4 - $10.45 $7,770 - $15,037	-1,439 Reduced 80.8%	342 $3,000
Q4 2019 Feb 14, 2020	BUY	$4.1 - $6.21 $7,302 - $11,060	1,781 New	1,781 $10,000
Q3 2019 Nov 14, 2019	SELL	$3.24 - $7.35 $13,643 - $30,950	-4,211 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.48 - $3.76 $3,846 - $5,831	1,551 Added 58.31%	4,211 $13,000
Q1 2019 May 14, 2019	SELL	$2.84 - $4.18 $54,192 - $79,762	-19,082 Reduced 87.77%	2,660 $8,000
Q4 2018 Feb 14, 2019	BUY	$3.76 - $5.61 $74,880 - $111,723	19,915 Added 1090.04%	21,742 $82,000
Q3 2018 Nov 14, 2018	BUY	$4.22 - $6.03 $658 - $940	156 Added 9.34%	1,827 $11,000
Q2 2018 Aug 14, 2018	BUY	$5.53 - $15.4 $9,240 - $25,733	1,671 New	1,671 $9,000
Q1 2018 May 15, 2018	SELL	$11.62 - $17.32 $12,874 - $19,190	-1,108 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.8 - $17.31 $13,074 - $19,179	1,108	1,108 $13,000

Others Institutions Holding SCPH

# of Institutions

Shares Held

37.1M

Call Options Held

110K

Put Options Held

12.1K

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $93.7M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account